Month: August 2012

 “The process for reviewing and approving new cancer drugs in Canada takes almost twice as long as that in the United States and is longer than the approval times in Europe, concludes a new report from the Fraser Institute, Canada’s leading public policy think-tank.  The result has Canadians waiting significantly longer for new, potentially life-saving […]

“Corporate businesses are flush with cash, which they still seem hesitant to deploy, presumably due to the uncertain economic outlook,” said David Madani, Canadian economist for the London-based research firm. “This obviously leaves scope for firms to increase dividends, which could boost personal income and consumption significantly.” In a recent research note, Mr. Madani said […]